The global hairy cell leukemia market size is anticipated to expand at a robust CAGR during the forecast period, 2021-2028. The growth of the market is attributed to rising awareness about the hairy cell leukemia coupled with rising disposable income. Moreover, increasing diagnosis rate of hairy cell leukemia is driving the market growth.
Hairy cell leukemia is a rare type of blood cancer that is caused due to abnormal growth of B- cells. The outgrown B cells or B lymphocyte when examined under a microscope looks similar to hair extending from the surface area, which gives the cancer its name. Hairy cell leukemia is characterized by the uncontrolled accumulation of lymphocytes by bone marrow.
Most of the affected individuals are males 50 years of age or older. Early diagnosis can help the patients live longer. There are advanced diagnostic tests to detect the hairy cell leukemia. In one of the diagnostic tests, the blood profile indicates the total number of lymphocytes, which indicates the disease. Physicians can easily diagnose the cancer by physical examination. Most of the patients also require bone marrow biopsy for confirmation.
The report on the global hairy cell leukemia market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes | Details |
Report Title | Hairy Cell Leukemia market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year | 2020 |
Historic Data | 2018–2019 |
Forecast Period | 2021–2028 |
Segmentation | Therapies (Chemotherapy and Targeted Therapy) |
Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report | Hoffmann-La Roche Ltd, Janssen Global Services LLC, Dr.Reddy's Laboratories, Emcure Pharmaceuticals, Amgen Inc., Hospira, Astex Therapeutics, Pfizer Inc, AstraZeneca plc, BioGenomics Limited, Incyte Corp, Merck & Co Inc, Genentech, bluebird bio, Beam Therapeutics, Mission Bio, Roivant Sciences Inc., Humanigen, Fate Therapeutics, Kronos Bio, Tasso, PTC Therapeutics, Quantgene, Syros Pharmaceuticals, Oncoternal, GlycoMimetics, Notable Labs, Nuprobe, CARsgen, and Twinstrand Biosciences Inc. |
Based on therapies, the market is divided into chemotherapy and targeted therapy. The chemotherapy is anticipated to account for a key share and is anticipated to grow at a robust rate during the forecast period. Chemotherapy drugs, such as cladribine and pentostatin, are considered as an initial treatment option for most individuals with hairy cell leukemia. This factor is driving the segment growth. However, the targeted therapy segment is expected to grow at a healthy CAGR owing to ongoing R&D activities for the hairy cell leukemia treatment.
On the basis of regions, the market is segregated into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America to account for a large market share owing to advancements in technologies, high incidence, and increasing geriatric population. Conversely, the market in Asia Pacific is expected to register a substantial growth rate in global hairy cell leukemia market during the forecast period.
Segments Covered in the Report
The global hairy cell leukemia market has been segmented on the basis of
Therapies
Regions
Key Players
The major players of the market are Hoffmann-La Roche Ltd, Janssen Global Services LLC, Dr.Reddy's Laboratories, Emcure Pharmaceuticals, Amgen Inc., Hospira, Astex Therapeutics, Pfizer Inc, AstraZeneca plc, BioGenomics Limited, Incyte Corp, Merck & Co Inc, Genentech, bluebird bio, Beam Therapeutics, Mission Bio, Roivant Sciences Inc., Humanigen, Fate Therapeutics, Kronos Bio, Tasso, PTC Therapeutics, Quantgene, Syros Pharmaceuticals, Oncoternal, GlycoMimetics, Notable Labs, Nuprobe, CARsgen, and Twinstrand Biosciences Inc.
Companies are focusing on innovation, partnerships, and acquisitions to expand their market share.
Some other reports from this category!